A prolyl endopeptidase from Flammulina velutipes for the possible degradation of celiac disease provoking toxic peptides in cereal proteins
Massy, M., Marti, S., Hammer, H., & Hoepner, R
Platform Overview: MEDVi's Telehealth GLP-1 Weight Loss Model Heading into the 2026 New Year weight loss season, a growing number of consumers are seeking affordable alternatives to brand-name GLP-1 medications that typically cost $1,300-1,500/month without insurance coverage
S.BartlettS
Given the pre-existing data on GLP-1 and glucagon, we designed a double-blinded randomised cross-over study, in which we gave volunteers who were overweight short-term intravenous infusions of glucagon (50 ng/kg/min or 14 pmol/kg/min), GLP-1 (0.8 pmol/kg/min), combination of glucagon + GLP-1 at the same doses, or placebo over 45 minutes, and demonstrated that there was a significant increase in resting energy expenditure with glucagon alone which was preserved with the combination of glucagon + GLP-1, whereas GLP-1 did not affect energy expenditure (66)